The impact of the Alzheimer's Disease Neuroimaging Initiative 2: What role do public-private partnerships have in pushing the boundaries of clinical and basic science research on Alzheimer's disease?

被引：16

作者：

Jones-Davis, Dorothy M. ^{[1
]}

Buckholtz, Neil ^{[2
]}

机构：

[1] Fdn Natl Inst Hlth, Bethesda, MD 20892 USA

[2] NIA, NIH, Bethesda, MD 20892 USA

来源：

ALZHEIMERS & DEMENTIA | 2015年 / 11卷 / 07期

关键词：

ADNI; Alzheimer's disease; Public private partnerships; Consortia; FNIH; NIA; Foundation for the National Institutes of Health; National Institute on Aging; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; RECOMMENDATIONS; MILD;

D O I：

10.1016/j.jalz.2015.05.006

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

In the growing landscape of biomedical public-private-partnerships, particularly for Alzheimer's disease, the question is posed as to their value. What impacts do public-private-partnerships have on clinical and basic science research in Alzheimer's disease? The authors answer the question using the Alzheimer's Disease Neuroimaging Initiative (ADNI) as a test case and example. ADNI is an exemplar of how public-private-partnerships can make an impact not only on clinical and basic science research and practice (including clinical trials), but also of how similar partnerships using ADNI as an example, can be designed to create a maximal impact within their fields. (C) 2015 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

引用

页码：860 / 864

页数：5

共 50 条

[1] The role of the Alzheimer's Association in the genesis of Alzheimer's Disease Neuroimaging Initiative
Carrillo, Maria C.
Mahinrad, Simin
Snyder, Heather M.
Khachaturian, Zaven
ALZHEIMERS & DEMENTIA, 2024, 20 (11) : 8183 - 8187
[2] Alzheimer's disease public-private partnerships: Update 2014
Snyder, Heather M.
Kim, Hye
Bain, Lisa J.
Egge, Robert
Carrillo, Maria C.
ALZHEIMERS & DEMENTIA, 2014, 10 (06) : 873 - 880
[3] Alzheimer's disease public-private partnerships: Update 2017
Snyder, Heather M.
Perlman, William R.
Egge, Robert
Carrillo, Maria C.
ALZHEIMERS & DEMENTIA, 2018, 14 (04) : 522 - 531
[4] Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2
Jack, Clifford R., Jr.
Barnes, Josephine
Bernstein, Matt A.
Borowski, Bret J.
Brewer, James
Clegg, Shona
Dale, Anders M.
Carmichael, Owen
Ching, Christopher
DeCarli, Charles
Desikan, Rahul S.
Fennema-Notestine, Christine
Fjell, Anders M.
Fletcher, Evan
Fox, Nick C.
Gunter, Jeff
Gutman, Boris A.
Holland, Dominic
Hua, Xue
Insel, Philip
Kantarci, Kejal
Killiany, Ron J.
Krueger, Gunnar
Leung, Kelvin K.
Mackin, Scott
Maillard, Pauline
Malone, Ian B.
Mattsson, Niklas
McEvoy, Linda
Modat, Marc
Mueller, Susanne
Nosheny, Rachel
Ourselin, Sebastien
Schuff, Norbert
Senjem, Matthew L.
Simonson, Alix
Thompson, Paul M.
Rettmann, Dan
Vemuri, Prashanthi
Walhovd, Kristine
Zhao, Yansong
Zuk, Samantha
Weiner, Michael
ALZHEIMERS & DEMENTIA, 2015, 11 (07) : 740 - 756
[5] Perspective: The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partner Scientific Board (PPSB)
Liu, Enchi
Luthman, Johan
Cedarbaum, Jesse M.
Schmidt, Mark E.
Cole, Patricia E.
Hendrix, James
Carrillo, Maria C.
Jones-Davis, Dorothy
Tarver, Erika
Novak, Gerald
De Santi, Susan
Soares, Holly D.
Potter, William Z.
Siemers, Eric
Schwarz, Adam J.
ALZHEIMERS & DEMENTIA, 2015, 11 (07) : 840 - 849
[6] Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative
Veitch, Dallas P.
Weiner, Michael W.
Aisen, Paul S.
Beckett, Laurel A.
Cairns, Nigel J.
Green, Robert C.
Harvey, Danielle
Jack, Clifford R., Jr.
Jagust, William
Morris, John C.
Petersen, Ronald C.
Saykin, Andrew J.
Shaw, Leslie M.
Toga, Arthur W.
Trojanowski, John Q.
Aisen, Paul
Weiner, Michael
Petersen, Ronald
Trojanowki, John Q.
Toga, Arthur W.
Beckett, Laurel
Morris, John
Khachaturian, Zaven
Sorensen, Greg
Carrillo, Maria
Kuller, Lew
Raichle, Marc
Paul, Steven
Davies, Peter
Fillit, Howard
Hefti, Franz
Holtzman, David
Mesulam, M. Marcel
Potter, William
Snyder, Peter
Montine, Tom
Jimenez, Gustavo
Donohue, Michael
Gessert, Devon
Harless, Kelly
Salazar, Jennifer
Cabrera, Yuliana
Walter, Sarah
Hergesheimer, Lindsey
Harvey, Danielle
Bernstein, Matthew
Fox, Nick
Thompson, Paul
Schuff, Norbert
DeCArli, Charles
ALZHEIMERS & DEMENTIA, 2019, 15 (01) : 106 - 152
[7] The Alzheimer's Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans
Kang, Ju-Hee
Korecka, Magdalena
Figurski, Michal J.
Toledo, Jon B.
Blennow, Kaj
Zetterberg, Henrik
Waligorska, Teresa
Brylska, Magdalena
Fields, Leona
Shah, Nirali
Soares, Holly
Dean, Robert A.
Vanderstichele, Hugo
Petersen, Ronald C.
Aisen, Paul S.
Saykin, Andrew J.
Weiner, Michael W.
Trojanowski, John Q.
Shaw, Leslie M.
ALZHEIMERS & DEMENTIA, 2015, 11 (07) : 772 - 791
[8] Clinical core of the Alzheimer's disease neuroimaging initiative: Progress and plans
Aisen, Paul S.
Petersen, Ronald C.
Donohue, Michael C.
Gamst, Anthony
Raman, Rema
Thomas, Ronald G.
Walter, Sarah
Trojanowski, John Q.
Shaw, Leslie M.
Beckett, Laurel A.
Jack, Clifford R., Jr.
Jagust, William
Toga, Arthur W.
Saykin, Andrew J.
Morris, John C.
Green, Robert C.
Weiner, Michael W.
ALZHEIMERS & DEMENTIA, 2010, 6 (03) : 239 - 246
[9] Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014
Weiner, Michael W.
Veitch, Dallas P.
Aisen, Paul S.
Beckett, Laurel A.
Cairns, Nigel J.
Cedarbaum, Jesse
Donohue, Michael C.
Green, Robert C.
Harvey, Danielle
Jack, Clifford R.
Jagust, William
Morris, John C.
Petersen, Ronald C.
Saykin, Andrew J.
Shaw, Leslie
Thompson, Paul M.
Toga, Arthur W.
Trojanowski, John Q.
ALZHEIMERS & DEMENTIA, 2015, 11 (07) : 865 - 884
[10] Clinical Observational Research on Alzheimer's Disease: What Clinical Trial Registries Can Tell
Dal-Re, Rafael
Fauria, Karine
Gramunt, Nina
Luis Molinuevo, Jose
JOURNAL OF ALZHEIMERS DISEASE, 2013, 34 (01) : 183 - 190

← 1 2 3 4 5 →